One of the outpatient rehab options for individuals in Duluth struggling with opioid abuse and addiction is called opioid maintenance therapy. Some centers and doctors are authorized to administer certain meds to opioid dependent individuals, many that are opioid-based also and are addiction. With low doses however, the user doesn't experience high feelings but also does not experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first med administered for this reason, but there are alternative choices currently to select from.
Methadone is an opioid and can be taken at an out-patient clinic licensed to administer the drug, which is taken daily as a pill or liquid. The cost of the drug is around under $200 per month. Buprenorphine is also an opioid-based med, and is a pill often taken one day on, one day off. But different from Methadone that is only be dispensed in highly structured clinics, Buprenorphine can be prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately $300.00 /month for the generic version of the drug. There is also a type of buprenorphine that contains naloxone, that is a med which reverses the effects of opiates. A person consuming this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It too is taken on a daily basis, and costs about $450 monthly. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and is not an opioid. A person has the choice to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 a month.
There are 1 Drug and Alcohol Rehabilitation Facilities offering this service in Duluth, MN
For All Drug and Alcohol Rehabilitation Programs In Duluth, Click Here.